Tower Research Capital LLC (Trc) Contrafect Corp Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.09 - $0.19 $0 - $1	-10 Reduced 10.0%	90 $0
Q3 2022 Nov 10, 2022	SELL	$0.18 - $3.51 $3 - $70	-20 Reduced 16.67%	100 $0
Q2 2022 Aug 15, 2022	BUY	$2.79 - $4.45 $334 - $534	120 New	120 $0
Q1 2022 May 12, 2022	SELL	$2.26 - $3.84 $15,155 - $25,751	-6,706 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.47 - $4.14 $16,563 - $27,762	6,706 New	6,706 $17,000
Q2 2021 Aug 16, 2021	SELL	$3.58 - $4.9 $107,886 - $147,666	-30,136 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$4.46 - $6.68 $95,818 - $143,513	21,484 Added 248.31%	30,136 $144,000
Q4 2020 Feb 16, 2021	SELL	$5.05 - $6.4 $32,380 - $41,036	-6,412 Reduced 42.57%	8,652 $44,000
Q3 2020 Nov 16, 2020	BUY	$5.05 - $6.99 $72,674 - $100,593	14,391 Added 2138.34%	15,064 $80,000
Q2 2020 Aug 13, 2020	BUY	$4.69 - $7.81 $3,156 - $5,256	673 New	673 $4,000

49.2K

Ticker CFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,332,700
Market Cap $1.18M
Description
ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.